← Leaderboards
Alexis Cassandra Thompson
State University Of New York At Buffalo
$1,720,360
Attributed
$2,140,913
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $615K · FY2006–10$1M$750K$500K$250K$0
'06
'07
'08
'09
'10
Funding mix
By agency
NIH$2,140,913 · 2
By mechanism
R01$1,510,083 · 1
R21$630,830 · 1
Top collaborators
- Jun Qu2 shared
- Robert M Straubinger2 shared
Most similar at State University Of New York At Buffalo
Same institution · by research overlap
- David M Dietz$7,195,683
- Jun-Xu Li$5,236,253
- Yun Wu$3,163,825
- Rebecca Ashare$9,515,606
- Jerome Allan Roth$2,683,173
Others in their field
Top investigators on “Relapse”
- Ralph Parchment · Leidos Biomedical Research, Inc.$141,315,269
- Charles A Coltman · Southwest Oncology Group$124,514,512
- Mary M Horowitz · Medical College Of Wisconsin$85,160,686
- Monica M Bertagnolli · Strang Cancer Prevention Center$41,995,734
- Effie W Petersdorf · Fred Hutchinson Cancer Research Center$29,676,600
- Misty Ward Stevens · Intervexion Therapeutics, Llc$28,867,910
Research focus
RelapseDependenceRecording Of Previous EventsStressEvaluationCocaineDrug ExposureRattusWithdrawalCharacteristicsPharmaceutical PreparationsDesignAnimal ModelDriving BehaviorDrug Delivery SystemsBehaviorDisturbance In AffectDrug DesignBrainCrimeCommunicable DiseasesCravingAgonistCommunities
Grant awards (7)
Peripheral biomarkers of cocaine dependence and relapse$313,830
R21 · FY2010 · DA
Evaluation of Neuropeptide Y as a Target for Cocaine-Dependence Treatment$280,625
R01 · FY2010 · DA · contact PI
Peripheral biomarkers of cocaine dependence and relapse$317,000
R21 · FY2009 · DA
Evaluation of Neuropeptide Y as a Target for Cocaine-Dependence Treatment$297,979
R01 · FY2009 · DA · contact PI
Evaluation of Neuropeptide Y as a Target for Cocaine-Dependence Treatment$298,288
R01 · FY2008 · DA · contact PI
Evaluation of Neuropeptide Y as a Target for Cocaine-Dependence Treatment$304,700
R01 · FY2007 · DA · contact PI
Evaluation of Neuropeptide Y as a Target for Cocaine-Dependence Treatment$328,491
R01 · FY2006 · DA · contact PI